Renaissance Technologies
RLAY icon

Renaissance Technologies’s Relay Therapeutics RLAY Stock Holding History

Renaissance Technologies’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Sell
192,399
-481,200
-71% -$6.99M 0.01% 1638
2026
Q1 		$6.7M Buy
673,599
+25,700
+4% +$230K 0.01% 1191
2025
Q4 		$5.48M Sell
647,899
-375,211
-37% -$2.68M 0.01% 1250
2025
Q3 		$5.34M Sell
1,023,110
-485,100
-32% -$1.85M 0.01% 1453
2025
Q2 		$5.22M Sell
1,508,210
-767,900
-34% -$2.28M 0.01% 1499
2025
Q1 		$5.96M Buy
2,276,110
+726,920
+47% +$2.85M 0.01% 1323
2024
Q4 		$6.38M Buy
1,549,190
+878,095
+131% +$4.78M 0.01% 1287
2024
Q3 		$4.75M Sell
671,095
-237,942
-26% -$1.78M 0.01% 1469
2024
Q2 		$5.93M Buy
909,037
+145,837
+19% +$996K 0.01% 1200
2024
Q1 		$6.33M Buy
763,200
+439,500
+136% +$4.29M 0.01% 1262
2023
Q4 		$3.56M Buy
323,700
+179,000
+124% +$1.51M 0.01% 1563
2023
Q3 		$1.22M Buy
+144,700
New +$1.56M ﹤0.01% 2167
2023
Q2 		– Sell
-118,854
Closed -$1.96M – 4216
2023
Q1 		$1.96M Buy
118,854
+58,054
+95% +$1.04M ﹤0.01% 2041
2022
Q4 		$908K Buy
+60,800
New +$1.16M ﹤0.01% 2590
2022
Q3 		– Sell
-25,900
Closed -$434K – 4347
2022
Q2 		$434K Sell
25,900
-1,900
-7% -$40.7K ﹤0.01% 3237
2022
Q1 		$832K Buy
27,800
+20,800
+297% +$505K ﹤0.01% 2852
2021
Q4 		$215K Sell
7,000
-145,588
-95% -$4.6M ﹤0.01% 3482
2021
Q3 		$4.81M Buy
+152,588
New +$5.14M 0.01% 1488

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Renaissance Technologies's RLAY Position: Q2 2026 in Review

Renaissance Technologies reduced its Relay Therapeutics (RLAY) stake by 71% in Q2 2026, selling an estimated $6.99M and leaving 192,399 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #1638.

Renaissance Technologies first reported a position in RLAY in Q3 2021 and has held it in 18 quarters since. The position peaked at $6.7M in Q1 2026. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Renaissance Technologies held 192,399 shares of Relay Therapeutics worth $3.6M as of Q2 2026.
  • Renaissance Technologies sold 481,200 Relay Therapeutics shares in Q2 2026, an estimated $6.99M.
  • Relay Therapeutics made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1638 holding.
  • Renaissance Technologies first reported a position in Relay Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • Renaissance Technologies's Relay Therapeutics position peaked at $6.7M in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.